サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676264

副鼻腔炎治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Sinusitis Treatment Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 126 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
副鼻腔炎治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 126 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

副鼻腔炎治療の世界市場規模は、2024年の29億9,000万米ドルから2033年までには52億7,000万米ドルに成長し、2026年から2033年の予測期間中に6.52％の堅調な年間平均成長率（CAGR）を示すと予測されます。

副鼻腔炎治療市場は、副鼻腔炎の有病率の増加と効果的な治療オプションに対する需要の高まりにより、大きな成長を遂げています。汚染やアレルゲンなどの環境要因が副鼻腔炎の罹患率上昇に寄与しているため、ヘルスケアプロバイダーは症状を緩和し、患者の予後を改善する革新的な治療法を模索しています。同市場には、薬物療法、点鼻薬、外科的介入など、さまざまな治療オプションがあり、ドラッグ製剤やデリバリーシステムの進歩が治療効果を高めています。また、標的治療薬や生物学的製剤の開発も進んでおり、慢性副鼻腔炎を管理し、侵襲的な処置の必要性を減らすための新たな手段を提供しています。

さらに、患者中心の治療が重視されるようになり、副鼻腔炎治療市場に影響を与えています。患者が治療方針の決定に関与するようになるにつれ、個々の症状や選好を考慮した個別化された治療計画に対する需要が高まっています。この動向により、ヘルスケアプロバイダーは副鼻腔炎の管理によりホリスティックなアプローチを採用し、従来の治療に加えてライフスタイルの改善や代替療法を取り入れるようになっています。

さらに、耳鼻咽喉科領域における研究開発への注目の高まりが、副鼻腔炎治療市場の技術革新を促進しています。製薬会社、医療機器メーカー、研究機関の協力により、治療手法や技術の進歩が促進され、新製品が患者の進化するニーズに確実に応えています。また、副鼻腔炎がQOLに与える影響に対する意識の高まりも、症状緩和のための効果的な解決策を求める患者の増加に伴い、市場の成長に寄与しています。まとめると、副鼻腔炎治療市場は、技術の進歩、個別化治療の重視、患者の転帰改善への取り組みなどを特徴とし、力強い成長を遂げようとしています。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳します。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価をします。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 副鼻腔炎治療産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 副鼻腔炎治療の世界市場分析：疾患タイプ別

  • 概要：疾患タイプ別
  • 過去と予測データ分析：疾患タイプ別
  • 急性副鼻腔炎
  • 亜急性副鼻腔炎
  • 慢性副鼻腔炎

第6章 副鼻腔炎治療の世界市場分析：治療別

  • 概要：治療別
  • 過去と予測データ分析：治療別
  • 鎮痛薬
  • 抗生物質（セファロスポリン系、マクロライド系、ペニシリン系）
  • 抗ヒスタミン薬
  • 手術（内視鏡・バルーン副鼻腔形成術）
  • コルチコステロイド
  • スルホンアミド
  • キノロン系抗菌薬

第7章 副鼻腔炎治療の世界市場分析：投与経路別

  • 概要：投与経路別
  • 過去と予測データ分析：投与経路別
  • 外用薬
  • 鼻腔
  • 経口
  • 注射剤

第8章 副鼻腔炎治療の世界市場分析：流通チャネル別

  • 概要：流通チャネル別
  • 過去と予測データ分析：流通チャネル別
  • オンライン薬局
  • 小売薬局
  • 病院薬局

第9章 副鼻腔炎治療の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第10章 副鼻腔炎治療企業の競合情勢

  • 副鼻腔炎治療市場の競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Pfizer Inc.
  • GlaxoSmithKline Plc
  • Sanofi
  • Johnson & Johnson（Janssen Pharmaceuticals Inc.）
  • Bayer AG
  • AstraZeneca Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Inc.
  • Dr. Reddy'S Laboratories Inc.
  • Mylan N.V.
  • Hikma Pharmaceuticals Plc
  • Wockhardt
  • Amneal Pharmaceuticals LLC
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Disease Type (USD MN)
  • Acute Sinusitis Market Sales By Geography (USD MN)
  • Sub-acute Sinusitis Market Sales By Geography (USD MN)
  • Chronic Sinusitis Market Sales By Geography (USD MN)
  • Analysis By Treatment (USD MN)
  • Analgesics Market Sales By Geography (USD MN)
  • Antibiotics (Cephalosporin, Macrolide, and Penicillin) Market Sales By Geography (USD MN)
  • Antihistamines Market Sales By Geography (USD MN)
  • Surgery (Endoscopy and Balloon Sinuplasty) Market Sales By Geography (USD MN)
  • Corticosteroids Market Sales By Geography (USD MN)
  • Sulfonamides Market Sales By Geography (USD MN)
  • Quinolones Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Nasal Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Global Sinusitis Treatment Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Sinusitis Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Sinusitis Treatment Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Disease Type
  • Market Attractiveness Analysis By Treatment
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Disease Type (USD MN)
  • Acute Sinusitis Market Sales By Geography (USD MN)
  • Sub-acute Sinusitis Market Sales By Geography (USD MN)
  • Chronic Sinusitis Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment (USD MN)
  • Analgesics Market Sales By Geography (USD MN)
  • Antibiotics (Cephalosporin, Macrolide, and Penicillin) Market Sales By Geography (USD MN)
  • Antihistamines Market Sales By Geography (USD MN)
  • Surgery (Endoscopy and Balloon Sinuplasty) Market Sales By Geography (USD MN)
  • Corticosteroids Market Sales By Geography (USD MN)
  • Sulfonamides Market Sales By Geography (USD MN)
  • Quinolones Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Nasal Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11212129

Global Sinusitis Treatment Market size is anticipated to grow from USD 2.99 Billion in 2024 to USD 5.27 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.52% during the forecast period of 2026 to 2033.

The sinusitis treatment market is experiencing significant growth, driven by the increasing prevalence of sinusitis and the rising demand for effective therapeutic options. As environmental factors, such as pollution and allergens, contribute to the growing incidence of sinusitis, healthcare providers are seeking innovative treatments to alleviate symptoms and improve patient outcomes. The market encompasses a range of treatment options, including medications, nasal sprays, and surgical interventions, with advancements in drug formulations and delivery systems enhancing the effectiveness of therapies. The development of targeted therapies and biologics is also gaining traction, providing new avenues for managing chronic sinusitis and reducing the need for invasive procedures.

Moreover, the growing emphasis on patient-centric care is influencing the sinusitis treatment market. As patients become more involved in their treatment decisions, there is a rising demand for personalized treatment plans that consider individual symptoms and preferences. This trend is prompting healthcare providers to adopt a more holistic approach to sinusitis management, integrating lifestyle modifications and alternative therapies alongside conventional treatments.

Furthermore, the increasing focus on research and development in otolaryngology is fostering innovation in the sinusitis treatment market. Collaborations between pharmaceutical companies, medical device manufacturers, and research institutions are driving advancements in treatment methodologies and technologies, ensuring that new products meet the evolving needs of patients. The growing awareness of the impact of sinusitis on quality of life is also contributing to market growth, as more individuals seek effective solutions for symptom relief. In summary, the sinusitis treatment market is set for robust growth, characterized by technological advancements, a focus on personalized care, and a commitment to improving patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Disease Type

  • Acute Sinusitis
  • Sub-acute Sinusitis
  • Chronic Sinusitis

By Treatment

  • Analgesics
  • Antibiotics (Cephalosporin, Macrolide, and Penicillin)
  • Antihistamines
  • Surgery (Endoscopy and Balloon Sinuplasty)
  • Corticosteroids
  • Sulfonamides
  • Quinolones

By Route of Administration

  • Topical
  • Nasal
  • Oral
  • Injectable

By Distribution Channel

  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
  • COMPANIES PROFILED
  • Sun Pharmaceutical Industries Inc.
  • Pfizer Inc.
  • Janssen Pharmaceuticals Inc. (Johnson & Johnson)
  • Fresenius Kabi USA LLC
  • Dr. Reddy's Laboratories Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • Merck & Co Inc.
  • AstraZeneca plc
  • Amneal Pharmaceuticals LLC
  • GlaxoSmithKline plc
  • Apotex Inc.
  • Hikma Pharmaceuticals pic
  • Wockhardt
  • Mylan N.V.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. SINUSITIS TREATMENT INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease Type
    • 3.7.2 Market Attractiveness Analysis By Treatment
    • 3.7.3 Market Attractiveness Analysis By Route of Administration
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SINUSITIS TREATMENT MARKET ANALYSIS BY DISEASE TYPE

  • 5.1. Overview By Disease Type
  • 5.2. Historical and Forecast Data Analysis By Disease Type
  • 5.3. Acute Sinusitis Historic and Forecast Sales By Regions
  • 5.4. Sub-acute Sinusitis Historic and Forecast Sales By Regions
  • 5.5. Chronic Sinusitis Historic and Forecast Sales By Regions

6. GLOBAL SINUSITIS TREATMENT MARKET ANALYSIS BY TREATMENT

  • 6.1. Overview By Treatment
  • 6.2. Historical and Forecast Data Analysis By Treatment
  • 6.3. Analgesics Historic and Forecast Sales By Regions
  • 6.4. Antibiotics (Cephalosporin, Macrolide, and Penicillin) Historic and Forecast Sales By Regions
  • 6.5. Antihistamines Historic and Forecast Sales By Regions
  • 6.6. Surgery (Endoscopy and Balloon Sinuplasty) Historic and Forecast Sales By Regions
  • 6.7. Corticosteroids Historic and Forecast Sales By Regions
  • 6.8. Sulfonamides Historic and Forecast Sales By Regions
  • 6.9. Quinolones Historic and Forecast Sales By Regions

7. GLOBAL SINUSITIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1. Overview By Route of Administration
  • 7.2. Historical and Forecast Data Analysis By Route of Administration
  • 7.3. Topical Historic and Forecast Sales By Regions
  • 7.4. Nasal Historic and Forecast Sales By Regions
  • 7.5. Oral Historic and Forecast Sales By Regions
  • 7.6. Injectable Historic and Forecast Sales By Regions

8. GLOBAL SINUSITIS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Online Pharmacies Historic and Forecast Sales By Regions
  • 8.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Hospital Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL SINUSITIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE SINUSITIS TREATMENT COMPANIES

  • 10.1. Sinusitis Treatment Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF SINUSITIS TREATMENT INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Pfizer Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. GlaxoSmithKline Plc
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Sanofi
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Johnson & Johnson (Janssen Pharmaceuticals Inc.)
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Bayer AG
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. AstraZeneca Plc
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Merck & Co. Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Novartis AG
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Teva Pharmaceutical Industries Ltd.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Sun Pharmaceutical Industries Inc.
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Dr. Reddy'S Laboratories Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Mylan N.V.
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Hikma Pharmaceuticals Plc
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Wockhardt
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Amneal Pharmaceuticals LLC
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies